Assuntos
Implante Coclear , Implantes Cocleares , Surdez , Humanos , Adulto , Criança , Adolescente , Surdez/cirurgia , Surdez/reabilitaçãoRESUMO
987 hospitalized patients with various cardiovascular diseases were studied for the side effects of the cardiovascular drugs applied. 12 patients (1.2%) were admitted to the hospital because of drug side effects. During the course of hospital treatment 193 types of drug side effects were registered in III patients (11.24%). 128 (66.32%) of the side effects were due to pharmacologic causes, the remaining were of immunologic character. Most of the patients suffering from drug side effects were women--60 (61.4%), and 64.84% of the patients were over 50 years of age. Most of the drug side effects were caused by coronary vasodilating drugs (31.53%), followed by calcium antagonists (18%), cardiac glycosides (12.6%), etc. The need of knowledge of the risks related to the use of cardiovascular drugs as well as the control of the untoward reactions in the course of treatment are pointed out.
Assuntos
Fármacos Cardiovasculares/efeitos adversos , Adulto , Idoso , Idoso de 80 Anos ou mais , Envelhecimento/efeitos dos fármacos , Bulgária , Doenças Cardiovasculares/complicações , Doenças Cardiovasculares/tratamento farmacológico , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Fatores de RiscoRESUMO
The study is based on the statistical data of 3317 hospitalized patients 310 of whom (9.34%) were hospitalized because of a drug untoward reaction. The drug side effects are more frequent in women (60.64%) than in men (39.35%). The most affected age groups are those of 20-29 and 30-39 years. 74.21% of the untoward reactions are of immune character and the remaining are pharmacologic. The greater part of the untoward reactions are due to the following drugs: noramidopyrine (10.4%), co-trimoxazole (9.07%), acetylsal (8.21%) and amoxycillin (6.23%). Most frequently affected are: the skin (44.41%), the central and peripheral nervous system (17.41%) and the cardiovascular system (11.06%).